NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 77 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $33,000 | -45.9% | 35,400 | -22.9% | 0.00% | – |
| Q4 2015 | $61,000 | -41.9% | 45,900 | 0.0% | 0.00% | – |
| Q3 2015 | $105,000 | +41.9% | 45,900 | 0.0% | 0.00% | – |
| Q2 2015 | $74,000 | +13.8% | 45,900 | +12.5% | 0.00% | – |
| Q1 2015 | $65,000 | -36.9% | 40,800 | -25.4% | 0.00% | – |
| Q4 2014 | $103,000 | +14.4% | 54,700 | -19.9% | 0.00% | – |
| Q3 2014 | $90,000 | -10.9% | 68,300 | 0.0% | 0.00% | – |
| Q2 2014 | $101,000 | -19.2% | 68,300 | +1.0% | 0.00% | – |
| Q1 2014 | $125,000 | -32.8% | 67,596 | -24.6% | 0.00% | – |
| Q4 2013 | $186,000 | -52.8% | 89,696 | -39.7% | 0.00% | – |
| Q3 2013 | $394,000 | -7.9% | 148,696 | -7.2% | 0.00% | – |
| Q2 2013 | $428,000 | – | 160,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sowell Financial Services LLC | 1,507,457 | $593,000 | 0.17% |
| Harel Insurance Investments & Financial Services Ltd. | 780,000 | $398,000 | 0.03% |
| Spark Investment Management LLC | 353,400 | $180,000 | 0.01% |
| LifePlan Financial Group, Inc | 28,810 | $15,000 | 0.01% |
| Greenwich Wealth Management LLC | 60,066 | $31,000 | 0.01% |
| SHINE INVESTMENT ADVISORY SERVICES INC | 19,608 | $10,000 | 0.01% |
| Virtu KCG Holdings LLC | 336,414 | $172,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $9,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $331,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 377,875 | $193,000 | 0.00% |